Baseline characteristics of patients with Kawasaki disease (KD). Data are mean (range) unless otherwise indicated.
| Characteristic | |
|---|---|
| Age, yrs | 4.6 (1.9–10.5) |
| Sex, male/female | 10/10 |
| Fulfillment of KD criteria | 5/6: 5 cases |
| 6/6: 15 cases | |
| Day receiving initial IVIG | 4.3 (3–6) |
| Dose of initial IVIG, g/kg | 3.6 (3–4) |
| Other medications, no. cases | |
| ASA | 12 |
| Flurbiprofen | 8 |
| Ulinastatin | 2 |
| Symptoms of KD before IFX | |
| Fever, °C | 39.1 (38.4–40.5) |
| Bilateral bulbar conjunctival injection | 20 cases |
| Changes in lips and oral cavity | 20 cases |
| Cervical lymphadenopathy | 20 cases |
| Polymorphous exanthema | 15 cases |
| Change in extremities | 20 cases |
| Laboratory findings before IFX | |
| White blood cell count, per μl | 17,304 (8,400–30,600) |
| Neutrophil count, % | 75.6 (50.5–91.7) |
| Platelet count, (× 104/μl) | 43.0 (18.9–76.1) |
| Serum albumin, g/dl | 2.30 (1.6–3.1) |
| C-reactive protein, mg/dl | 14.8 (5.0–36.8) |
| Coronary abnormalities | 20 cases |
IVIG: intravenous immunoglobulin; IFX: infliximab; ASA: acetylsalicylic acid.